Showing results (1-10 of 56) with videos related to
Sort By:
Pageof 6
Human Vaccines|July 24, 2007
Plants as alternative systems for production of vaccinesJessica A Chichester, Vidadi YusibovExpert Review of Vaccines|April 8, 2009
Using plant cells as influenza vaccine substratesJessica A Chichester, Lars R Haaheim, Vidadi YusibovHuman Gene Therapy Methods|April 19, 2018
Assessment of Humoral, Innate, and T-Cell Immune Responses to Adeno-Associated Virus VectorsRoberto Calcedo, Jessica A Chichester, James M WilsonImmunology|June 10, 2006
Transient inhibition of Th1-type cytokine production by CD4 T cells in hepatitis B core antigen immunized mice is mediated by regulatory T cellsJessica A Chichester, Mark A Feitelson, Catherine E CalkinsJournal of Immunological Methods|January 19, 2006
Different response requirements for IFNgamma production in ELISPOT assays by CD4+ T cells from mice early and late after immunizationJessica A Chichester, Mark A Feitelson, Catherine E CalkinsJournal of Pharmaceutical Sciences|November 25, 2014
Influence of protein formulation and carrier solution on asymmetrical flow field-flow fractionation: a case study of the plant-produced recombinant anthrax protective antigen pp-PA83Caroline Palais, Jessica A Chichester, Slobodanka Manceva, et al.Human Vaccines & Immunotherapeutics|December 9, 2016
Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slicesAngela Temann, Tatiana Golovina, Vanessa Neuhaus, et al.Vaccine|February 10, 2009
A single component two-valent LcrV-F1 vaccine protects non-human primates against pneumonic plagueJessica A Chichester, Konstantin Musiychuk, Christine E Farrance, et al.Journal of Biomedical Materials Research. Part A|July 31, 2015
Controlled release of an anthrax toxin-neutralizing antibody from hydrolytically degradable polyethylene glycol hydrogelsYingkai Liang, Megan V Coffin, Slobodanka D Manceva, et al.Viruses|December 4, 2012
Safety and immunogenicity of a plant-produced recombinant hemagglutinin-based influenza vaccine (HAI-05) derived from A/Indonesia/05/2005 (H5N1) influenza virus: a phase 1 randomized, double-blind, placebo-controlled, dose-escalation study in healthy adultsJessica A Chichester, R Mark Jones, Brian J Green, et al.Pageof 6